Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Total Non-Current Liabilities (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $65.0 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 4.8% to $65.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.0 million through Dec 2025, up 4.8% year-over-year, with the annual reading at $65.0 million for FY2025, 4.8% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $65.0 million at Harvard Bioscience, up from $62.5 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $81.1 million in Q1 2022, with the low at $60.1 million in Q2 2024.
  • Average Total Non-Current Liabilities over 5 years is $68.5 million, with a median of $65.7 million recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities rose 13.73% in 2022, then decreased 14.07% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $78.5 million in 2021, then decreased by 8.06% to $72.1 million in 2022, then decreased by 12.92% to $62.8 million in 2023, then fell by 1.22% to $62.0 million in 2024, then increased by 4.8% to $65.0 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $65.0 million, $62.5 million, and $62.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.